Amneal Pharmaceuticals Class Stock Performance
| AMRX Stock | USD 14.82 0.19 1.30% |
On a scale of 0 to 100, Amneal Pharmaceuticals holds a performance score of 21. The firm shows a Beta (market volatility) of 0.17, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Amneal Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Amneal Pharmaceuticals is expected to be smaller as well. Please check Amneal Pharmaceuticals' treynor ratio, as well as the relationship between the expected short fall and day median price , to make a quick decision on whether Amneal Pharmaceuticals' price patterns will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Amneal Pharmaceuticals Class are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Amneal Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.5 | Five Day Return 3.69 | Year To Date Return 19.98 | Ten Year Return (56.59) | All Time Return 219.79 |
1 | Amneal EVP Sells 1.6 Million in Shares as Stock Trades Near Multi-Year Highs | 11/21/2025 |
2 | The Bull Case For Amneal Pharmaceuticals Could Change Following Key FDA Wins For Epinephrine And Complex Generics | 12/10/2025 |
3 | Amneal Pharmaceuticals Eyes 2026 Growth at JPMorgan, Crexont Sales Seen Doubling in 2025 | 01/14/2026 |
4 | Assessing Amneal Pharmaceuticals Valuation After Recent Share Price Momentum | 01/21/2026 |
5 | Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026 | 01/27/2026 |
6 | Amneal Pharmaceuticals Added to SP SmallCap 600 Index | 01/28/2026 |
7 | Amneal Pharmaceuticals Valuation After Opioid Settlement Finalization And SP Index Additions | 02/05/2026 |
8 | What Amneal Pharmaceuticals s Index Additions and Opioid Settlement Mean For Shareholders | 02/10/2026 |
| Begin Period Cash Flow | 99.1 M | |
| Total Cashflows From Investing Activities | -63 M |
Amneal Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 1,152 in Amneal Pharmaceuticals Class on November 20, 2025 and sell it today you would earn a total of 330.00 from holding Amneal Pharmaceuticals Class or generate 28.65% return on investment over 90 days. Amneal Pharmaceuticals Class is currently generating 0.4403% in daily expected returns and assumes 1.5933% risk (volatility on return distribution) over the 90 days horizon. In different words, 14% of stocks are less volatile than Amneal, and 92% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Amneal Pharmaceuticals Target Price Odds to finish over Current Price
The tendency of Amneal Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 14.82 | 90 days | 14.82 | roughly 2.22 |
Based on a normal probability distribution, the odds of Amneal Pharmaceuticals to move above the current price in 90 days from now is roughly 2.22 (This Amneal Pharmaceuticals Class probability density function shows the probability of Amneal Stock to fall within a particular range of prices over 90 days) .
Amneal Pharmaceuticals Price Density |
| Price |
Predictive Modules for Amneal Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Amneal Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Amneal Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Amneal Pharmaceuticals is not an exception. The market had few large corrections towards the Amneal Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Amneal Pharmaceuticals Class, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Amneal Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.38 | |
β | Beta against Dow Jones | 0.17 | |
σ | Overall volatility | 0.95 | |
Ir | Information ratio | 0.21 |
Amneal Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Amneal Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Amneal Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 2.79 B. Net Loss for the year was (73.88 M) with profit before overhead, payroll, taxes, and interest of 1.09 B. | |
| Amneal Pharmaceuticals has a strong financial position based on the latest SEC filings | |
| About 46.0% of the company shares are held by company insiders | |
| Latest headline from simplywall.st: What Amneal Pharmaceuticals s Index Additions and Opioid Settlement Mean For Shareholders |
Amneal Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Amneal Stock often depends not only on the future outlook of the current and potential Amneal Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amneal Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 309 M | |
| Cash And Short Term Investments | 112.4 M |
Amneal Pharmaceuticals Fundamentals Growth
Amneal Stock prices reflect investors' perceptions of the future prospects and financial health of Amneal Pharmaceuticals, and Amneal Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amneal Stock performance.
| Return On Equity | -8.81 | ||||
| Return On Asset | 0.0679 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 7.14 B | ||||
| Shares Outstanding | 314.36 M | ||||
| Price To Earning | 230.50 X | ||||
| Price To Book | 86.10 X | ||||
| Price To Sales | 1.63 X | ||||
| Revenue | 2.79 B | ||||
| Gross Profit | 1.09 B | ||||
| EBITDA | 439.77 M | ||||
| Net Income | (73.88 M) | ||||
| Cash And Equivalents | 87.33 M | ||||
| Cash Per Share | 0.58 X | ||||
| Total Debt | 2.59 B | ||||
| Current Ratio | 1.74 X | ||||
| Book Value Per Share | (0.35) X | ||||
| Cash Flow From Operations | 295.1 M | ||||
| Earnings Per Share | 0.01 X | ||||
| Market Capitalization | 4.78 B | ||||
| Total Asset | 3.5 B | ||||
| Retained Earnings | (607.06 M) | ||||
| Working Capital | 458.04 M | ||||
| Current Asset | 753.39 M | ||||
| Current Liabilities | 310.2 M | ||||
About Amneal Pharmaceuticals Performance
Evaluating Amneal Pharmaceuticals' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Amneal Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Amneal Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 144.95 | 178.38 | |
| Return On Tangible Assets | (0.06) | (0.06) | |
| Return On Capital Employed | 0.12 | 0.11 | |
| Return On Assets | (0.04) | (0.04) | |
| Return On Equity | 1.23 | 1.29 |
Things to note about Amneal Pharmaceuticals performance evaluation
Checking the ongoing alerts about Amneal Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amneal Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 2.79 B. Net Loss for the year was (73.88 M) with profit before overhead, payroll, taxes, and interest of 1.09 B. | |
| Amneal Pharmaceuticals has a strong financial position based on the latest SEC filings | |
| About 46.0% of the company shares are held by company insiders | |
| Latest headline from simplywall.st: What Amneal Pharmaceuticals s Index Additions and Opioid Settlement Mean For Shareholders |
- Analyzing Amneal Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amneal Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Amneal Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Amneal Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amneal Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Amneal Pharmaceuticals' stock. These opinions can provide insight into Amneal Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals' price analysis, check to measure Amneal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals is operating at the current time. Most of Amneal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.